Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $114.35 million as of June 18, 2025. Its market cap has increased by 47.55% in one year.

• Market Cap: 114.35M
• Enterprise Value: 98.97M
• 1-Year Change: 47.55%
• Ranking: #4027
• Category: Micro-Cap
• Stock Price: $3.55

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $114.35M, an increase of 37.44%. That is a compound annual growth rate of 1.20%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2025	118.50M	58.63%
Dec 31, 2024	74.70M	-38.06%
Dec 29, 2023	120.60M	-7.44%
Dec 30, 2022	130.30M	46.40%
Dec 31, 2021	89.00M	21.92%
Dec 31, 2020	73.00M	10.11%
Dec 31, 2019	66.30M	-10.04%
Dec 31, 2018	73.70M	106.44%
Dec 29, 2017	35.70M	-24.52%
Dec 30, 2016	47.30M	79.85%
Dec 31, 2015	26.30M	10.04%
Dec 31, 2014	23.90M	-39.34%
Dec 31, 2013	39.40M	18.32%
Dec 31, 2012	33.30M	73.44%
Dec 30, 2011	19.20M	-39.81%
Dec 31, 2010	31.90M	-65.14%
Dec 31, 2009	91.50M	61.95%
Dec 31, 2008	56.50M	-63.00%
Dec 31, 2007	152.70M	62.27%
Dec 29, 2006	94.10M	31.24%
Dec 30, 2005	71.70M	-0.42%
Dec 31, 2004	72.00M	94.07%
Dec 31, 2003	37.10M	183.21%
Dec 31, 2002	13.10M	-52.88%
Dec 31, 2001	27.80M	-35.94%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	735.57B
Johnson & Johnson	377.99B
Novo Nordisk	355.28B
AbbVie	337.52B
Regencell Bioscience Holdings	294.27B
UnitedHealth Group	284.42B
Abbott Laboratories	235.96B
Novartis AG	234.52B